Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, has announced the acquisition of VaxTRIALS. Headquartered in Panama City, Panama, VaxTRIALS’ 160+ staff members manage and monitor vaccine clinical trial activities throughout Latin America. “VaxTRIALS is a highly complementary match for Emmes,” elaborated Emmes Chief Executive Officer Peter Ronco. “It extends our global reach from our current base in North America, Europe and Asia to Latin America, one of the fastest-growing regions for clinical trials due to its large, diverse patient population and high-quality clinical research sites.”
Read the full article: Emmes Acquires VaxTRIALS //
Source: https://www.prnewswire.com/news-releases/emmes-acquires-vaxtrials-301947737.html